Profile
Cyberdyne Inc. is a pioneering Japanese robotics and medical technology company founded in June 2004 as a university venture from the University of Tsukuba. Headquartered in Tsukuba, Ibaraki Prefecture, the company is best known for developing HAL® (Hybrid Assistive Limb), the world’s first cyborg-type robot (Wearable Cyborg™) that improves, supports, enhances, and regenerates the wearer’s physical functions based on their bio-electric signals. Founded by Professor Yoshiyuki Sankai, Cyberdyne coined the term “Cybernics” — a new academic field fusing humans, robots, and information systems — to create technologies that address super-aging society challenges in healthcare, welfare, labor, and daily life.
Cyberdyne’s core innovation lies in its HAL technology, which reads faint bio-electric signals from the wearer’s skin to detect movement intentions and assist or enhance motion in real time. This neurological feedback loop helps patients with spinal cord injuries, strokes, neuromuscular diseases, and other mobility impairments regain natural movement and improve locomotor function, even in chronic stages. The system is used in both medical rehabilitation and non-medical support settings.
Key robot-based products include:
- Medical HAL Lower Limb Type: A CE-marked and FDA-cleared exoskeleton for neurorehabilitation. It supports patients with lower-limb disorders (e.g., spinal cord injury, stroke) by assisting voluntary movements and promoting neural regeneration. Versions are available for different regions (JP and EU).
- Medical HAL Single Joint Type: Targets specific joint rehabilitation (e.g., knee or elbow) for more focused therapy.
- Non-Medical HAL Series: Includes lower-limb and lumbar support models for daily living assistance, labor support (e.g., heavy lifting), and self-reliance. Examples include HAL for Labor Support and HAL for Care/Support.
- Other Products: Disinfection/cleaning robots (CL02), transport robots, and Acoustic X (sound-based systems).
Cyberdyne operates globally with a focus on clinical evidence, regulatory compliance (CE, FDA), and real-world impact. The company continues to expand Cybernics applications across medical treatment, welfare, and industrial labor support.
Map
Sorry, no records were found. Please adjust your search criteria and try again.
Sorry, unable to load the Maps API.




